Hepeng Shi is the founder of Avistone Pharmaceuticals. Avistone Pharmaceuticals has raised $340M in total funding. Latest round: Series A.
Hepeng Shi is a Beijing-based biotechnology entrepreneur associated with Avistone Pharmaceuticals, a clinical-stage company focused on precision oncology therapeutics. His efforts led to one of the largest-ever Series A rounds for a China biotech, creating a new company from a pair of start-ups.
Full founder directory · Investor directory · Company funding database · Fundraising library